Loratadine USP, a tricyclic antihistamine.
10mg once daily (one oral lyophilisate tablet).
Chew the tablet before swallowing. It can be taken without regard to mealtime.
No dosage adjustments are required.
It is a selective, peripheral H1-receptor antagonist, blocking the action of histamine.
No, not clinically significant at recommended dosage.
Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children over 2 years old (over 30kg).
Hypersensitivity reactions, dizziness, convulsions, tachycardia, nausea, dry mouth, gastritis, abnormal hepatic function, rash, alopecia, fatigue.
Hypersensitivity to Loratadine.
Caution with severe liver impairment. Discontinue at least 48 hours before skin tests.
Preferably avoid use during pregnancy.
Not recommended as Loratadine is excreted in breast milk.
Potential interactions with CYP3A4 or CYP2D6 inhibitors.
Contact a medical professional immediately.
Below 30°C, protected from light, out of reach of children.
Ratnatris Pharmaceuticals Pvt. Ltd., manufactured for KESSINGTON GLOBAL SYNERGY LTD.